Inventor · disambiguated record
Mikiko Nakamura
Also filed as: NAKAMURA MIKIKO
8 granted patents·6 pending applications·12 citations·filing 2011–2022
79Inventor score
Files withGENEFRONTIER CORP5CHUGAI PHARMACEUTICAL CO LTD4AKADA RINJI2KANAMORI TAKASHI1KOJOH KANEHISA1
Top patents by PatentIndex Score
14 records- 0183US10782300B2GPC3-targeting drug which is administered to patient responsive to GPC3-targeting drug therapyCHUGAI PHARMACEUTICAL CO LTD·Filed 2013·Granted Sep 22, 2020·4 cites·21 claims
- 0282US8633029B2Agent for improving gene transfer efficiency to mammalian cellsAKADA RINJI·Filed 2011·Granted Jan 21, 2014·6 cites·5 claims
- 0368US9796973B2Terminator sequence-containing reverse primer for overexpression and linear DNAAKADA RINJI·Filed 2012·Granted Oct 24, 2017·1 cites·7 claims
- 0459US10865247B2Anti-human CD69 antibody, and use thereof for medical purposesGENEFRONTIER CORP·Filed 2020·Granted Dec 15, 2020·0 cites·12 claims
- 0559US10640573B2Human antibody against aggrecanase-type ADAMTS species for therapeutics of aggrecanase-related diseasesUNIV KEIO·Filed 2018·Granted May 5, 2020·0 cites·7 claims
- 0657US9493523B2RNF8-FHA domain-modified protein and method of producing the sameKOJOH KANEHISA·Filed 2011·Granted Nov 15, 2016·1 cites·8 claims
- 0753US2024115578A1Drug composition for treating pediatric cancersCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0850US2022348658A1Anti-t cell antigen-binding molecule to be used in combination with cytokine inhibitorCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
- 0950US2019233521A1Anti-human cd69 antibody, and use thereof for medical purposesGENEFRONTIER CORP·Filed 2018·Application pending·0 cites
- 1048US9175327B2Composition for synthesizing protein with reduced lipopolysaccharide contamination, method for producing protein using said compositionKANAMORI TAKASHI·Filed 2011·Granted Nov 3, 2015·0 cites·12 claims
- 1148US2015118237A1Anti-human cd69 antibody, and use thereof for medical purposesGENEFRONTIER CORP·Filed 2013·Application pending·0 cites
- 1248US2020216542A1Dosage regimen for combination therapy using pd-1 axis binding antagonists and gpc3 targeting agentCHUGAI PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 1348US2016304622A1Human antibody against aggrecanase-type adamts species for therapeutics of aggrecanase-related diseasesGENEFRONTIER CORP·Filed 2014·Application pending·0 cites
- 1446US9617533B2Composition for synthesizing protein with reduced lipopolysaccharide contamination, method for producing protein using said compositionGENEFRONTIER CORP·Filed 2015·Granted Apr 11, 2017·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Mikiko Nakamura files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →